Tacrolimus for the Treatment of Focal Segmental Glomerulosclerosis Resistant to Cyclosporine A
Overview
Pediatrics
Authors
Affiliations
Treatment of patients with systemic-onset juvenile idiopathic arthritis with tacrolimus.
Wang D, Chen X, Li Z Exp Ther Med. 2019; 17(3):2305-2309.
PMID: 30783487 PMC: 6364178. DOI: 10.3892/etm.2019.7174.
Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
Aizawa-Yashiro T, Tsuruga K, Watanabe S, Oki E, Ito E, Tanaka H Pediatr Nephrol. 2011; 26(8):1255-61.
PMID: 21479767 DOI: 10.1007/s00467-011-1876-z.
Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus.
Roberti I, Vyas S Pediatr Nephrol. 2010; 25(6):1117-24.
PMID: 20217433 DOI: 10.1007/s00467-010-1471-8.
A novel multidrug therapy for difficult cyclosporine-resistant focal segmental glomerulosclerosis.
Oki E, Tsuruga K, Kudo M, Tsugawa K, Suzuki K, Tanaka H Pediatr Nephrol. 2008; 24(4):873-5.
PMID: 18949490 DOI: 10.1007/s00467-008-1033-5.
Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus.
Tanaka H, Tsugawa K, Suzuki K, Oki E, Nonaka K, Kimura S Eur J Pediatr. 2006; 166(10):1053-5.
PMID: 17187256 DOI: 10.1007/s00431-006-0380-0.